#emergency use authorization

State-run pharmaceutical firm PT Bio Farma has begun the phase three clinical trial of the locally-made COVID-19 ...

Bio Farma President Director Honesti Basyir confirmed that the state-owned enterprises (SOE) COVID-19 vaccine, ...

State-owned pharmaceutical company PT Bio Farma (Persero) did not conduct an efficacy study of the Red and White ...

State-owned pharmaceutical company PT Bio Farma (Persero) is exploring the possibility of exporting its Merah Putih ...

The Phase 3 clinical trials for the Red and White vaccine will begin in the second week of June this year and ...

Main researcher of the Merah Putih Vaccine clinical trial at Airlangga University, (Unair) Surabaya, Dr. Dominicus ...

The Health Ministry has started to gradually allocate Sinovac vaccines for the booster vaccination program to entire ...

The third phase of Merah Putih Vaccine's clinical trial is conducted in parallel with the booster trial, Merah ...

Around 1.53 million doses of COVID-19 vaccines potentially hit their expiration date in April this year, according to ...

Data from Merah Putih Vaccine's phase-1 clinical trial for COVID-19 whose vaccine seeds are developed by Unair, is ...

The Health Ministry has extended the validity period of 18 million vaccines that were set to expire in March this year ...

News Focus

The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the ...

The participants of the Merah Putih (Red and White) vaccine’s clinical trial will be observed for one year, lead ...

At least 140,420,471 Indonesians have received both doses of the COVID-19 vaccine so far, according to data released by ...

PT Kalbe Farma Tbk and PT Amarox Global Pharma announced that they have begun marketing Movfor (Molnupiravir), the ...